180 related articles for article (PubMed ID: 8826561)
21. [Definitive end-stage chronic kidney failure after cisplatin treatment].
Brillet G; Deray G; Lucsko M; Faucher C; Aubert P; Rottembourg J; Jacobs C
Nephrologie; 1993; 14(5):227-9. PubMed ID: 8159252
[TBL] [Abstract][Full Text] [Related]
22. [Renal protection with amifostine during intraoperative peritoneal chemohyperthermia (IPCH) with cisplatin (CDDP) for peritoneal carcinosis. Phase 1 study].
Vaira M; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Med; 2001 Aug; 92(4):207-11. PubMed ID: 11535965
[TBL] [Abstract][Full Text] [Related]
23. Lower Blood Pressure-Induced Renal Hypoperfusion Promotes Cisplatin-Induced Nephrotoxicity.
Mizuno T; Hayashi T; Shimabukuro Y; Murase M; Hayashi H; Ishikawa K; Takahashi K; Yuzawa Y; Yamada S; Nagamatsu T
Oncology; 2016; 90(6):313-20. PubMed ID: 27225867
[TBL] [Abstract][Full Text] [Related]
24. Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.
Hinai Y; Motoyama S; Niioka T; Miura M
J Clin Pharm Ther; 2013 Dec; 38(6):498-503. PubMed ID: 24102360
[TBL] [Abstract][Full Text] [Related]
25. Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors.
Pedram B; Moghadam AT; Kamyabi-Moghaddam Z; Mavedati O; Beigi BA; Sharabiyani AK; Dezfuli AB; Khalili S; Bahrami AM; Nasoori A
Tumour Biol; 2015 Jun; 36(6):4495-500. PubMed ID: 25596088
[TBL] [Abstract][Full Text] [Related]
26. Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals.
Suddek GM
Cancer Chemother Pharmacol; 2011 May; 67(5):1035-44. PubMed ID: 20652569
[TBL] [Abstract][Full Text] [Related]
27. Measures of renal function in patients with cisplatin-related chronic renal disease.
Reed E; Jacob J; Brawley O
J Natl Med Assoc; 1991 Jun; 83(6):522-6. PubMed ID: 1865503
[TBL] [Abstract][Full Text] [Related]
28. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
Santos NA; Bezerra CS; Martins NM; Curti C; Bianchi ML; Santos AC
Cancer Chemother Pharmacol; 2008 Jan; 61(1):145-55. PubMed ID: 17396264
[TBL] [Abstract][Full Text] [Related]
29. Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats.
Mundhe NA; Kumar P; Ahmed S; Jamdade V; Mundhe S; Lahkar M
Int Immunopharmacol; 2015 Sep; 28(1):634-42. PubMed ID: 26247680
[TBL] [Abstract][Full Text] [Related]
30. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity.
Ries F; Klastersky J
Am J Kidney Dis; 1986 Nov; 8(5):368-79. PubMed ID: 3538860
[TBL] [Abstract][Full Text] [Related]
31. Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study.
Komaki K; Kusaba T; Tanaka M; Kado H; Shiotsu Y; Matsui M; Shiozaki A; Nakano H; Ishikawa T; Fujiwara H; Konishi H; Itoh Y; Matoba S; Tamagaki K
BMC Cancer; 2017 Feb; 17(1):144. PubMed ID: 28219368
[TBL] [Abstract][Full Text] [Related]
32. Relationship of proximal fixation to renal dysfunction in patients undergoing endovascular aneurysm repair.
Mehta M; Cayne N; Veith FJ; Darling RC; Roddy SP; Paty PS; Ozsvath KJ; Kreienberg PB; Chang BB; Shah DM
J Cardiovasc Surg (Torino); 2004 Aug; 45(4):367-74. PubMed ID: 15365517
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of tongue squamous cell carcinoma under hemodialysis].
Watanabe A; Saito T
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1257-9. PubMed ID: 7661578
[No Abstract] [Full Text] [Related]
34. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the renal function using cystatin C level in the patients receiving cisplatin-based chemotherapy.
Kos FT; Sendur MA; Aksoy S; Sezer S; Civelek B; Yazici O; Yaman S; Eren T; Zengin N
Ren Fail; 2013; 35(5):705-10. PubMed ID: 23530579
[TBL] [Abstract][Full Text] [Related]
36. The evaluation of urinary calprotectin levels for prediction of acute cisplatin-induced nephrotoxicity.
Koçak G; Bilik G; Yeşilova A; Oyman F; Can M; Cihan Ş
Medicine (Baltimore); 2022 Jul; 101(26):e29814. PubMed ID: 35777022
[TBL] [Abstract][Full Text] [Related]
37. Acute renal failure and neurotoxicity following oral acyclovir.
Johnson GL; Limon L; Trikha G; Wall H
Ann Pharmacother; 1994 Apr; 28(4):460-3. PubMed ID: 8038467
[TBL] [Abstract][Full Text] [Related]
38. Renal tolerance to cisplatin in patients 70 years and older.
Cubillo A; Cornide M; López JL; Molina R; Feliu J; Espinosa E; Zamora P; de Castro J; Ordoñez A; González Barón M
Am J Clin Oncol; 2001 Apr; 24(2):192-7. PubMed ID: 11319297
[TBL] [Abstract][Full Text] [Related]
39. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
Sahu BD; Rentam KK; Putcha UK; Kuncha M; Vegi GM; Sistla R
Food Chem Toxicol; 2011 Dec; 49(12):3090-7. PubMed ID: 21930180
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin nephrotoxicity: experimental and clinical studies.
Daugaard G
Dan Med Bull; 1990 Feb; 37(1):1-12. PubMed ID: 2178884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
